戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  for Research and Treatment of Cancer Cancer Research Fund.
2 tle and the University of Washington Royalty Research Fund.
3 Council and University of Washington Royalty Research Fund.
4 e, Epilepsy Society, Dr Marvin Weil Epilepsy Research Fund.
5 onal Cancer Institute, and Children's Cancer Research Fund.
6 ed with allocating health-care resources and research funds.
7 y difficult for young researchers to procure research funds.
8 time as they do to acquire new buildings and research funds.
9 he subspecialty of basic science or clinical research funded.
10 0 grant to a young investigator for start-up research funding.
11 tion to their work, which can lead to future research funding.
12 ased radiology departments have little or no research funding.
13  analysis examining antibacterial resistance research funding.
14 r-control planning and priorities for public research funding.
15 ed, which limits the return on investment of research funding.
16 e events that stimulated public interest and research funding.
17 medical school was ranked highly in terms of research funding.
18 , current position and responsibilities, and research funding.
19 ts less likely than whites to be awarded NIH research funding.
20  garnered a mean of $410,755 in total annual research funding, 22.1% of all AMC research faculty were
21                This study compared total NIH research funding across US dental institutions from 2005
22 e impact this has on obtaining peer reviewed research funding after residency is unknown.
23 gly be a priority for health-care providers, research funding agencies, and policy makers in years to
24 gical and Scientific Development (CNPq), and Research Funding Agency of the State of Rio de Janeiro (
25 h Program, Stand Up To Cancer-Ovarian Cancer Research Fund Alliance-National Ovarian Cancer Coalition
26 e a national priority, with considerable new research funding allocated.
27 cer care systems and inform effective public research funds allocation.
28                        The 2007 World Cancer Research Fund/American Institute for Cancer Research (WC
29                             The World Cancer Research Fund/American Institute for Cancer Research Con
30                   In the recent World Cancer Research Fund/American Institute for Cancer Research rep
31                     In 2007 the World Cancer Research Fund and American Institute for Cancer Research
32                                     Thrasher Research Fund and Clinical Health Research Institute at
33                 Braun Anaesthesia Scientific Research Fund and Wu Jieping Medical Foundation, Beijing
34 oadly, and migraine in particular, have poor research funding and a limited academic base.
35  is an increasing relationship between NCCAM research funding and disease burden over the 4-year stud
36 y distance to researchers, locally available research funding and participation in data-sharing netwo
37    Overall evidence indicates that a lack of research funding and poor reproducibility of findings we
38 ost visible to health professionals, such as research funding and public health programmes, and invol
39 ives of industry, government (including both research funding and regulatory agencies), academia, and
40 ial mission score differ from those that use research funding and subjective assessments of school re
41 (CRUK/04/003), the June Hancock Mesothelioma Research Fund, and Guy's and St Thomas' NHS Foundation T
42  Psychiatry Research Trust, Maudsley Charity Research Fund, and th European Community's Seventh Frame
43  Psychiatry Research Trust, Maudsley Charity Research Fund, and th European Community's Seventh Frame
44  Plastic Surgeons, the Meirion Thomas Cancer Research Fund, and the National Institute for Health and
45 Foundation, Singapore National Cancer Centre Research Fund, and the US National Institutes of Health
46 etics Research Fund, Edward and Maybeth Sonn Research Fund, and US National Center for Research Resou
47 dical research, massive increases in federal research funding, and an increasingly large and speciali
48 and cancer followed substantial increases in research funding, and slowing the rising burden of respi
49  in coding, reimbursement from insurers, and research funding, and widespread education for clinician
50 rate, but parallel increases in capacity and research funding are going to be needed to translate thi
51 neficiaries of NIH support view advocacy for research funding as "someone else's job".
52 al Research Council Australia, Breast Cancer Research Fund, AstraZeneca, Sanofi Aventis.
53 ults should be of use to decision makers and research-funding authorities charged with allocating hea
54  We analyzed the focus and type of norovirus research funding awarded to institutions in the United S
55 MDs to the National Institutes of Health for research funding became less successful than application
56  through funding opportunities, working with research funding bodies to set the research agenda in th
57                                  Regulators, research funding bodies, and public policy makers may ne
58 s worsened, not only by the lack of targeted research funding, but also by the lack of relevant in-co
59 conformed to the institutional standards for research funded by a commercial sponsor.
60                                         Only research funded by public funding bodies was collected a
61           This abstract presents independent research funded by the National Institute for Health Res
62                                   Biomedical research funded by The National Institutes of Health and
63                                              Research funded by the NIH is becoming more concentrated
64 ould work together to increase the effect of research funding by strengthening national and internati
65             Despite substantial increases in research funding by the pharmaceutical industry, drug di
66  randomized phase 3 United Kingdom Leukaemia Research Fund Chronic Lymphocytic Leukemia 4 (UK LRF CCL
67 likely to receive NIH investigator-initiated research funding compared with whites.
68                                              Research funding data related to malaria for 1997-2013 w
69             (3) Globalization: US government research funding declined from 57% (2004) to 50% (2012)
70 tal US (public plus private) share of global research funding declining from 57% to 44%.
71  Disorders and Stroke, Keane Stroke Genetics Research Fund, Edward and Maybeth Sonn Research Fund, an
72 l Symposium of the Princess Takamatsu Cancer Research Fund, entitled "DNA Repair and Human Cancers,"
73                  Labex-IBEID, NIH-MIDAS, AXA Research fund, EU-PREDEMICS.
74                 Furthermore, many sources of research funding expect researchers to acknowledge any s
75 (Career Development Award); The Trust Family Research Fund for Kidney Cancer; US National Institutes
76                                              Research Fund for the Control of Infectious Disease (090
77 al Support Program of Guangdong, Specialized Research Fund for the Doctoral Program of Higher Educati
78  Faculty Development Awards, the Fundamental Research Funds for the Central Universities (2011jdhz62)
79 mmissioned grant from the Health and Medical Research Fund from the Government of the Hong Kong Speci
80                                     However, research funding from all sources will need to increase
81                                              Research funding from public and private sources has rea
82                          All authors receive research funding from the British Heart Foundation and D
83 ed States that receive the largest amount of research funding from the National Institutes of Health.
84  the 50 U.S. universities receiving the most research funding from the National Institutes of Health.
85 rs and less institutional support, including research funding from their institutions (46% compared w
86 fair and unbiased distribution of extramural research funds from the NIH.
87 ble Disease Dynamics, and Health and Medical Research Fund, Government of Hong Kong Special Administr
88          When adjusted for inflation, cancer research funding has actually declined 12% since 2004.
89 mental programs, recent growth in biomedical research funding has barely kept up with inflation.
90                Finally, we quantify how U.S. research funding has been distributed among these linkag
91                              1) Merit Review research funding has been essential to the training, rec
92                                              Research funding has to be aligned with prevailing and p
93 er, many instances of poor value from stroke research funding have resulted from the way in which str
94 ship and sustainability of the network after research funds have been expended.
95 n=2,823) of a prestigious grant for personal research funding in a national full population of early
96                 The stagnation of biomedical research funding in the US is placing great pressure on
97 dre of trained investigators, and sufficient research funding, including the development of an all pa
98                                   Biomedical research funding increased from $75.5 billion in 2003 to
99 portunities through novel business plans and research funding, increasing doctoral-level professional
100  are augmented by several factors, including research funding initiatives and the distinct demographi
101                                 World Cancer Research Fund International, European Commission (Marie
102                                      Seeking research funding is an essential part of academic life.
103                                 Governmental research funding is increasing (P <0.001).
104                          NIH's allocation of research funding is often disproportionate to the curren
105 e the importance of the Merit Review medical research funding mechanism not just to the VA, but to th
106 d (UNICEF) provided the largest value of non-research funding mentioning and exclusively benefitting
107                               Ovarian Cancer Research Fund, National Institutes of Health, California
108    This was the first systematic analysis of research funding of antibacterial resistance of this sca
109 groups: no author with a financial interest, research funding only, employment and leadership positio
110 s, patients and caregivers, and U.S. federal research funding organizations.
111  was not associated with either the level of research funding (P=0.89) or local rates of literacy (P=
112        Of pound13 846.1 million of available research funding, pound269.2 million (1.9%) was awarded
113 ly being used both for regulation and to set research funding priorities.
114 piled showing trends in US and international research funding, productivity, and disease burden by so
115                                  Constrained research funding prompts some to advocate training fewer
116 proposed that the amount of disease-specific research funding provided by the National Institutes of
117 is increase has been spurred on, in part, by research funding provided through private, parent advoca
118                                    Access to research funds, provision of incentives for acquisition
119 n African countries were ranked by amount of research funding received.
120                     In 2007 the World Cancer Research Fund Report concluded that there was limited an
121 ve received more than $1.8 billion in direct research funding since their PBF Fellowships began.
122 doubling, the rate of increase in biomedical research funding slowed from 2003 to 2007, and after adj
123 acteristics (e.g., age, institution, type of research), funding, sources of funding, and types of sup
124    All abstracts were categorized by type of research, funding status, number of centers, sample size
125 is analysis, we explore the possibility of a research funding strategy that would offer business ince
126                                     Thailand Research Fund, the Melioidosis Research Center, the Cent
127  for these variations include differences in research funding, the drug approval process, the role of
128 ong advocacy model to secure growing federal research funding, the physical sciences (including mathe
129 work discusses the effects of the decline in research funding, the plight of kidney research, and the
130 proaches to new data generation and required research funding to address this large public health bur
131  the allocation of health care resources and research funding to this major public health problem.
132 tical discoveries, increased competition for research funds, uncertainties on the reproducibility of
133 d fueled by increased number of researchers, research funding, venture capital and the number of star
134 evention recommendations of the World Cancer Research Fund (WCRF) and the American Institute for Canc
135                    In 2007, the World Cancer Research Fund (WCRF) and the American Institute for Canc
136                     In 2007 the World Cancer Research Fund (WCRF) and the American Institute of Cance
137 (2004) and 2.9% (2005) of abstracts only had research funding, whereas 7.3% (2004) and 6.9% (2005) ha
138 Considerable increases in public and private research funding will be required to develop and utilize
139 e from saturation of conventional sources of research funding without foreseeable opportunities for i

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top